Back to Agenda
PRIME Initiative Launch: Fostering Timely Access for Patient-Focused Drug Development
Session Chair(s)
Tomas Salmonson, DrMed, PhD
, Critical Path Institute, Netherlands
European Medicines Agency launched its new PRIME (PRIority MEdicines) scheme in March 2016 to strengthen support to medicines that address an unmet medical need. PRIME aims to bring promising innovative medicines to patients faster by optimising medicine development and facilitating accelerated assessment. The session will be the first opportunity for stakeholders to hear from and engage directly with EMA senior leadership and the CHMP chair, Tomas Salmonson, about PRIME. Participants will also get the opportunity to hear feedback from the patient perspective as EMA prepares to implement this critical initiative.
Speaker(s)
Jordi Llinares Garcia, MS
Head of Research and Innovation, European Medicines Agency, Netherlands
PRIME-ing the Development of Priority Medicines
Zaide Frias, PharmD
Head of Digital Business Transformation Task Force, European Medicines Agency, Netherlands
EMA’s Toolkit to Help Promote Innovation and Patient-Focused Development
Hans-Georg Eichler, MD, MSc
Consulting Physician, Austrian Association of Social Security Bodies, Austria
PRIME Impact on Patients and Public Health: The Bigger Picture
Have an account?